Analyst Ratings for Ironwood Pharmaceuticals (IRWD)
IRWD Rating Summary
IRWD Price Target Summary
- Highest: $10.00 (Citizens)
- Lowest: $3.70 (Jefferies)
- Average: $6.10
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
Avg. $ Target:
$6.10 (+74.3%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
Avg. $ Target:
$6.10 (+74.3%)
* Over Last 12-Mos
Rating Score: 4.1 / 10
Percentile Rank: 41%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/5/2026 | Craig-Hallum | Chase Knickerbocker | Upgrade | Buy (Hold) |
5.70 (N/A) |
4.27 (3.50) |
-18.03% | Details |
| 1/5/2026 | Citizens » Updated 2/26/2026 |
Jason Butler | Upgrade | Market Outperform (Market Perform) |
10.00 (8.00) |
3.37 (3.50) |
3.86% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
